White label – Pompe disease - ClinicalTrials.eu

Study on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Not recruiting

3 1
Investigated Diseases:
- Hypertrophic cardiomyopathy
Investigated Drugs:
- Aficamten
+5
Study of Baricitinib and Adalimumab for Children Aged 2 to 17 with Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Uveitis
Investigated Drugs:
- Adalimumab
- Baricitinib
Study on the Effectiveness and Safety of Obinutuzumab and Mycophenolate Mofetil in Children with Idiopathic Nephrotic Syndrome

Not recruiting

3 1 1 1
Investigated Drugs:
- Mycophenolate Mofetil
- Obinutuzumab
Study of XXB750 and Drug Combination for Patients with Heart Failure

Not recruiting

2 1 1
Investigated Diseases:
- Cardiac failure
Investigated Drugs:
+5
Study on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer’s Disease

Not recruiting

2 1 1
Investigated Drugs:
+2
Study on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome

Not recruiting

2 1
Investigated Drugs:
- Gemlapodect
Study on Cabozantinib for Patients with Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Thyroid cancer
Investigated Drugs:
- Cabozantinib
Study on Prednisolone Transfer into Breast Milk and Infant Plasma for Mothers with Rheumatoid Arthritis and Other Inflammatory Conditions

Not recruiting

3 1 1 1
Investigated Drugs:
- Betamethasone Sodium Phosphate
Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Not recruiting

2 1
Investigated Diseases:
- Rheumatoid arthritis
Investigated Drugs:
- Rosnilimab
+3
Study on the Safety and Effects of Livmoniplimab and Budigalimab in Patients with Advanced or Metastatic Solid Tumors

Not recruiting

1 1 1
Investigated Diseases:
- Malignant mast cell neoplasm
Investigated Drugs:
- Livmoniplimab
- Budigalimab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies